Preparation of mono- and diacylglycerols by enzymatic esterification of glycerol with conjugated linoleic acid in hexane von Martinez, C.E, Vinay, J.C, Brieva, R, Hill, C.G. Jr, Garcia, H.S

Volltext

Lipolysis of butteroil over an immobilized calf pre-gastric esterase : variation of rate and product distribution with temperature von GARCIA, H. S, VINAY, J. C, HILL, C. G

Volltext

Characterization of the technological and nutritive quality of improved and native tropical black beans (Phaseolus vulgaris L.) von Ortega, D.A, Vinay, J.C, Lopez, E

Volltext

Contenido de urea lactea en lactacion de bovinos en el tropico humedo Veracruzano von López-Solano, E, Villegas-Aparicio, Y, Gómez-Vázquez, A, Vinay-Vadillo, J.C, Mendoza-Martínez, G.D, Plascencia-Jorquera, A, Hernández-Garay, A, Hernández-Bautista, J, Carrillo-Rodríguez, J.C, Hernández-Santiago, J

Volltext

Immune-related adverse events with immune checkpoint blockade: a comprehensive review von Michot, J.M, Bigenwald, C, Champiat, S, Collins, M, Carbonnel, F, Postel-Vinay, S, Berdelou, A, Varga, A, Bahleda, R, Hollebecque, A, Massard, C, Fuerea, A, Ribrag, V, Gazzah, A, Armand, J.P, Amellal, N, Angevin, E, Noel, N, Boutros, C, Mateus, C, Robert, C, Soria, J.C, Marabelle, A, Lambotte, O

Volltext

Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours von Herin, H., Aspeslagh, S., Castanon, E., Dyevre, V., Marabelle, A., Varga, A., Postel Vinay, S., Michot, J.M., Ribrag, V., Gazzah, A., Bahleda, R., Mir, O., Massard, C., Hollebecque, A., Soria, J.C., Baldini, C.

Volltext

A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer von Postel-Vinay, S, Bajrami, I, Friboulet, L, Elliott, R, Fontebasso, Y, Dorvault, N, Olaussen, K A, André, F, Soria, J-C, Lord, C J, Ashworth, A

Volltext

Genetic architecture of transmission stage production and virulence in schistosome parasites von Le Clec'h, Winka, Chevalier, Frédéric D., McDew-White, Marina, Menon, Vinay, Arya, Grace-Ann, Anderson, Timothy J.C.

Volltext

Adapting the Marine Stewardship Council risk-based framework to estimate impacts on seabirds, marine mammals, marine turtles and sea snakes von Good, Stephanie D., Dewar, Kate, Burns, Polly, Sainsbury, Keith, Phillips, Richard A., Wallace, Bryan P., Fortuna, Caterina, Udyawer, Vinay, Robson, Bruce, Melvin, Edward F., Currey, Rohan J.C.

Volltext

SP-0258: Potentiation of anti-tumor immune effects by PARP Inhibitors von Chabanon, R., Muirhead, G., Krastev, D., Adam, J., Garrido, M., Morel, D., Dorvault, N., Pettitt, S., Tutt, A.N.J., Marabelle, A., Soria, J.C., Lord, C.J., Postel-Vinay, S.

Volltext

First-in-human phase I dose escalation study of the Bromodomain and Extra-Terminal motif (BET) inhibitor BAY 1238097 in subjects with advanced malignancies von Postel-Vinay, S, Herbschleb, K, Massard, C, Woodcock, V, Ocker, M, Wilkinson, G, Walter, A, Ewerton, F, Poelman, M, Middleton, M, Soria, J.C

Volltext

319 Risk factors of screen-failures in phase 1 clinical trials von Kempf, E, Lemoine, N, Tergemina-Clain, G, Turpin, A, Postel-Vinay, S, Lanoy, E, Soria, J.C, Hollebecque, A

Volltext

2631 Inclusion of patients with urothelial bladder cancer in phase 1 trials: What is the impact? von Turpin, A, Tergemina-Clain, G, Kempf, E, Postel-Vinay, S, Massard, C, Soria, J.C, Loriot, Y

Volltext

349 Impact of the re-definition of dose-limiting toxicities (DLTs) according to recent recommendations on the DLT rate in phase 1 trials of molecularly targeted agents von Helissey, C, Poterie, A, Massard, C, Hollebecque, A, Paoletti, X, Lanoy, E, Soria, J.C, Postel-Vinay, S

Volltext

A pathoanatomic approach to the management of mitral regurgitation von Badhwar, Vinay, MD, Smith, Anson J.C., MD, Cavalcante, João L., MD

Volltext

High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery von Isand, Kristina, Feelders, Richard, Brue, Thierry, Toth, Miklos, Deutschbein, Timo, Reincke, Martin, Krsek, Michal, Santos, Alicia, Demtröder, Frank, Chabre, Olivier, Strasburger, Christian J, Aulinas Maso, Anna, Volke, Vallo, Pereira, Alberto M, Lohmann, Rüdiger, Gich Saladich, Ignasi, Webb, Susan M, Wass, John, Valassi, Elena

Volltext

NAMPT inhibition is a novel synthetic lethal therapeutic approach exploiting nuclear–mitochondrial crosstalk in ERCC1-deficient populations von Touat, M, Olaussen, K, Sourisseau, T, Friboulet, L, Dorvault, N, Enot, D, Bigot, L, Pontoizeau, C, Mardakheh, F, Thompson, A, Bouillaud, F, Ricchetti, M, Ottolenghi, C, Pierron, G, Sarasin, A, Lombès, A, Ashworth, A, Lord, C, Soria, J.C, Postel-Vinay, S

Volltext

Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalu... von Yap, T.A, Krebs, M.G, Postel-Vinay, S, Bang, Y.J, El-Khoueiry, A, Abida, W, Harrington, K, Sundar, R, Carter, L, Castanon-Alvarez, E, Im, S.A, Berges, A, Khan, M, Stephens, C, Ross, G, Soria, J.C

Volltext

301 First-in-human phase I dose-escalation study of a MET/AXL/FGFR inhibitor, S 49076, in patients with advanced solid tumors von Azaro, A, Rodon, J, Herranz, M, Nuciforo, P, Prudkin, L, Lopez-Busto, N, Balandraud, S, Cattan, V, Jacquet-Bescond, A, Marfai, L, Pauly, J, Postel-Vinay, S, Hollebecque, A, Soria, J.C

Volltext

13LBA - First-in-human phase I dose escalation study of the Bromodomain and Extra-Terminal motif (BET) inhibitor BAY 1238097 in subjects with advanced malignancies von Postel-Vinay, S., Herbschleb, K., Massard, C., Woodcock, V., Ocker, M., Wilkinson, G., Walter, A., Ewerton, F., Poelman, M., Middleton, M., Soria, J.C.

Volltext